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Abstract
Background/Aims: Power and sample size calculation formulas for stepped-wedge trials with two levels (subjects within
clusters) are available. However, stepped-wedge trials with more than two levels are possible. An example is the CHANGE
trial which randomizes nursing homes (level 4) consisting of nursing home wards (level 3) in which nurses (level 2) are
observed with respect to their hand hygiene compliance during hand hygiene opportunities (level 1) in the care of patients.
We provide power and sample size methods for such trials and illustrate these in the setting of the CHANGE trial.
Methods: We extend the original sample size methodology derived for stepped-wedge trials based on a random inter-
cepts model, to accommodate more than two levels of clustering. We derive expressions that can be used to determine
power and sample size for p levels of clustering in terms of the variances at each level or, alternatively, in terms of
intracluster correlation coefficients. We consider different scenarios, depending on whether the same units in a particu-
lar level are repeatedly measured as a cohort sample or whether different units are measured cross-sectionally.
Results: A simple variance inflation factor is obtained that can be used to calculate power and sample size for continu-
ous and by approximation for binary and rate outcomes. It is the product of (1) variance inflation due to the multilevel
structure and (2) variance inflation due to the stepped-wedge manner of assigning interventions over time. Standard and
non-standard designs (i.e. so-called ‘‘hybrid designs’’ and designs with more, less, or no data collection when the clusters
are all in the control or are all in the intervention condition) are covered.
Conclusions: The formulas derived enable power and sample size calculations for multilevel stepped-wedge trials. For
the two-, three-, and four-level case of the standard stepped wedge, we provide programs to facilitate these calculations.
Keywords
Stepped-wedge trials, hybrid (stepped wedge) design, power, sample size, multilevel, variance inflation factor
Introduction
Hussey and Hughes1 and Girling and Hemming2
derived a power formula for the standard stepped-
wedge cluster-randomized design (see Figure 1) with
two levels of clustering (i.e. subjects within clusters),
where cross-sectional samples are taken at the lowest
(subject) level, that is, different subjects are measured
in every period. In this article, we derive and demon-
strate power and sample size calculations for stepped-
wedge cluster trials with more than two levels, in which
the lowest level is cross-sectional. One such example is
the CHANGE trial (ClinicalTrial.gov NCT02817282),
which aims to improve nurses’ level of compliance with
hand hygiene guidelines. This trial has four levels of
clustering, with nurses (level 2) in wards (level 3) of
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several nursing homes (level 4). Nurses are followed in
sessions where different opportunities for hand hygiene
arise and observations (level 1) on compliance to the
guideline are made.
If clusters consist of more than two levels, different
scenarios are possible. For example, in the CHANGE
trial that has four levels, the following scenarios are
possible (Figure 2):
Level 4 repeated: the same nursing homes are repeat-
edly measured (i.e. as a cohort) but in every measurement
period, different wards are measured, implying also that
different nurses and hygiene observations are made (i.e.
cross-sectional measurement at the lower levels).
Levels 4 and 3 repeated: the same wards within nur-
sing homes are repeatedly measured, but in every mea-
surement period, different nurses and hygiene
observations are made cross-sectionally over time.
Levels 4 and 3 and 2 repeated: the same nurses within
wards within nursing homes are repeatedly measured
(cohort design at these levels); in each measurement
period, different (i.e. cross-sectional) hygiene observa-
tions are made.
As illustrated in the range of possible scenarios
above, the highest level (referred to as a cluster in this
article) is always repeatedly measured and the lowest
level cross-sectionally. Up to a certain level, all levels
below this level are cross-sectionally measured, but lev-
els above it as cohort.
Our method covers both ‘‘standard’’ stepped-wedge
designs (i.e. designs where all clusters start in the con-
trol and end in the intervention condition) and non-
standard designs (i.e. stepped-wedge designs with more,
less, or no data collection before and/or after roll-out3
and hybrid designs;2 see Figure 1 with s= 4 stepped-
wedge sequences).
Methods
In order to support the flow of arguments, technical
derivations are provided in the Supplementary Files
(SF) and notations given in Table 1. At time t, cluster i
is either in the control condition (Xit= 0) or in the
intervention condition (Xit = 1). For power calcula-
tions, we make the simplifying assumption that the dif-
ferences between conditions, d, is the same wherever
and whenever the intervention is introduced and is
maintained at this level. Hussey and Hughes1 modeled
the clustering of subjects within clusters by a random
Figure 1. Cluster-randomized parallel group design and different stepped wedge like designs with s= 4 sequences. Each row
corresponds to a sequence in the design with the number of clusters in that sequence at the right side of the row. The background
color of a cell indicates the treatment (white for control and black for intervention) and the number within a cell gives the number
of repeated measurements. The total number of measurements is indicated below the design. Further details are provided in the
Supplementary Files (SF3, 4, and5).
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intercept for cluster (level 2 random effect). For more
than two levels, we extend this idea by incorporating
random effects for each clustering level. For example,
for four levels, the outcome Yitjkm of ‘‘observation’’
(level 1 unit) m= 1, . . . , n1 of ‘‘subject’’ (level 2 unit)
k= 1, . . . , n2 within ‘‘sub-cluster’’ (level 3 unit)
j= 1, . . . , n3 within ‘‘cluster’’ (level 4 unit) i= 1, . . . , I
in measurement/period t= 1, . . . , T is
Yitjkm=m+ u000i+ u00i(t)j+ u0i(t)jk +bt + dXit+ eitjkm,
u000i, u00i(t)j, u0i(t)jk random effects at levels 4, 3, and 2 with variances s
2
4,s
2
3, and s
2
2, respectively
eitjkm random effect (residual) at level 1,with variance s
2
1
fu000i, u00(it)j, u0(it)jk, eitjkmgmutually independent;
u00i(t)j, u00i(t0)j are equal (unequal) for t 6¼ t0 if level 3 measured as cohort (crosssectional);
u0i(t)jk , u0i(t0)jk are equal (unequal) for t 6¼ t0 if level 2 measured as cohort (crosssectional)
9>>>=
>>>>;
ð1Þ
If an intermediate level is measured as cohort, the
index (t) can be dropped. In this article, we assume that
at every measurement time/period (t= 1, 2, . . . , T )
1. All clusters (i= 1, 2, . . . , I) are measured;
2. Each level-2 unit (e.g. nurse) has the same number
n1 of level-1 units (e.g. observations); each level-3
unit (e.g. nursing home) has the same number n2 of
level-2 units (e.g. nurses), and so on.
3. Randomization is always on the highest level.
In terms of the cluster averages Yit at each time
point/period (so Yit=(
P
j, k,m Yitjkm)=(n1n2n3) for four
levels), we have a repeated measurement design, and
the above model implies equal covariance
t2=Cov(Yit, Yit0) between averages of the same cluster
over time, and equal variance Var(Yit)=s2+ t2 of
the clusters across all time/period (SF1). The variance
of the weighted least-squares estimator d^ for the inter-
vention effect is (Hussey & Hughes, 2007)
var d^
 
=
Is2 s2 + Tt2ð Þ
f Xð Þs2 + g Xð Þt2
f Xð Þ= S  I  C, g Xð Þ= S2+ S  I  T  R  I  C  T
S=SitXit, C=St SiXitð Þ2, R=Si StXitð Þ2
9>=
>;
ð2Þ
where S is the sum of matrix elements, C is the sum of
squared column sums, and R is the sum of squared row
sums of X =(Xit).
In terms of the correlation r= corr(Yit, Yit0)
between averages of the same cluster over time, we can
reformulate this as (SF2)
var d^
 
=
I  (1 r)  1+ T  1ð Þr½ 
f Xð Þ  1 rð Þ+ g Xð Þ  r  var Yitð Þ ð3Þ
or in equivalent formulation by Girling and Hemming2
(SF2)
var d^
 
= (1r)
I T  aD Xð ÞbD Xð ÞRð Þ  var Yitð Þ
aD Xð Þ= 1I T  Sit Xij  Xt
 2
,
bD Xð Þ= 1=I Sit Xi  Xð Þ2,
R= T r
1+ T1ð Þr
Xt=SiXit=I ,Xi=StXit=T , X=SitXit=(I  T ):
9>>>>=
>>>>;
ð4Þ
where aD is the within-column variance of (Xit) and bD
is the between-row variance. Note that r is not an
intracluster correlation coefficient, but it can be
expressed in terms of intracluster correlations of the
multilevel design (Table 2).
Taking f , g corresponding to a standard stepped-
wedge design, we get
var d^
 
=
6
I  s 1
s
   s2  1+ s2  t2
s2+ 1+ s
2
 
t2
" #
ð5aÞ
var d^
 
=
6  1 rð Þ
I  s 1
s
   1+ sr½ 
1+ s
2
r
   var Yitð Þ ð5bÞ
For two levels, equation (5b) reduces to the variance
formula in the appendix of the article by Woertman
et al.4
For f , g of the other designs, see SF4 and 5.
Impact of design and multilevel structure
The design (i.e. the specification of intervention/control
condition for each cluster at each time) influences
var(d^) via f , g or aD, bD, while the data generating
model (1) influences var(d^) via r and var(Yit) or,
equivalently, s2 and t2. Specifically, the number of lev-
els and the sample size at each level determine var(Yit),
while the specification of which levels are measured as
a cohort and which levels cross-sectionally determines
r (see Table 2).
As illustrated for the CHANGE trial in the section
‘‘Introduction,’’ various scenarios can arise because up
to a certain level, all units of lower levels are measured
cross-sectionally, and from that level upward, all levels
have their units measured repeatedly as cohort.
Relevant formulas for each possible scenario with two,
three, and four levels are provided in Table 2.
Derivation and implementation of these formulas in
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SAS and Excel programs are in the SF, which also
contains the results for more than four levels.
Variance inflation due to the multilevel structure
The factor var(Yit) in equations (3) and (4) is calculated
the same as in cluster-randomized trials with a parallel
group post-test (i.e. with one measurement) design. For
two levels, var(Yit)= 1+(n 1)ICC½   4s2tot=Ntot
where ICC= r12 is the intracluster correlation of sub-
jects within clusters and ½1+(n 1)ICC is the variance
inflation factor (VIF), also known as design effect5
(SF1.2). For more than two levels, variance inflation
factors due to the multiple levels of clustering can also
be used, and there are several ways to define these. One
is to define separate variance inflation factors for the
correlation of level 1 units in level 2 units, for the corre-
lation of level 2 units in level 3 units and so on;6,7
another is to define separate variance inflation factors
based on the correlation of level 1 units in the same
level 2 units, the correlation of level 1 units in the same
level 3 units, but different level 2 units, and so on.8,9
Both types of intracluster correlations and variance
inflation factors can be expressed in terms of the other
(SF1.1). Here, we use only the first mentioned type.
Then, the variance inflation for p levels is
VIFp= 1+ n1  1ð Þ12
   1+ n2  1ð Þ~r23½  . . .
1+ np1  1
 
~rp1, p
h i ð6Þ
To clarify the meaning of this in the CHANGE trial
setting, the intracluster correlation r12 is the true (pop-
ulation) correlation between any pair of observations
within the same nurse; the intracluster correlation r23 is
the correlation between true outcomes of two nurses
within the same ward; and so on. Because we only have
a sample of n1 observations per nurse, the true outcome
of the nurses can only be approximated by taking the
average of the observations per nurse, and therefore,
the correlation between the outcomes of two nurses
within the same home is attenuated to ~r23. The same
holds for the other correlations. More on the estima-
tion, interpretation and the attenuation of these
intracluster correlations can be found in the article by
Teerenstra et al.6
Variance inflation factor for stepped-wedge designs
Using equation (3) or (4) and the research by Girling
and Hemming2 and Thompson et al.,3 we provide var-
iance inflation factors for the p-level ‘‘standard’’
cluster-randomized stepped-wedge design with s
sequences, the stepped wedge with more/fewer/no
observations before and/or after roll-out, and the
hybrid design (SF8). We formulate these compared to a
p-level cluster-randomized parallel group design with
one measurement (cPG1) design
Figure 2. Scenarios in four-level stepped-wedge design
(CHANGE trial setting): (a) only nursing homes NH (level 4)
followed as cohort, (b) wards W (level 3) within nursing homes
(level 4) followed as cohort, and (c) nurses Nu (level 2) within
wards (level 3) in nursing homes (level 4) followed as cohort.
The boxed parts of the multilevel data are measured cross-
sectionally. In particular, the observations O (level 1) are always
measured cross-sectionally.
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VIFrm:cPG1=
VIFSWs:cPG1=
3
2
 1rð Þ 1+ srð Þ
s1
sð Þ 1+ s2rð Þ
VIFSWs a, bð Þ:cPG1=
3
2
 1rð Þ 1+ a+ b2+ s½ rð Þ
s1
sð Þ 1+ a+ b2+ s2½ rð Þ
VIFH b, sð Þ:cPG1=
1rð Þ
T
 1
1b2
3
1+ 2
s2
 
+R 1b
3
2+ 1
s2
  
8>><
>>:
9>>=
>>;
ð7Þ
and thus, the variance inflation factor compared to a
parallel group individually randomized design with one
measurement (using a t-test) is then
VIF=VIFrm:cPG1  VIFp ð8Þ
where VIFp is the variance inflation factor due to multi-
level structure as explained above.
From equation (8), we can see that the total variance
inflation comes from two aspects of the design: the
manner of assigning intervention over the measurement
times and the multilevel structure at each measurement
time.
Sample size and power calculation
As sample size formulas and programs for a parallel
group individually randomized designs with one mea-
surement (i.e. post-test design) are readily available,
sample size calculation for the stepped-wedge trial with
p levels can easily be performed by first calculating the
total sample size Ntot,PG1 (to detect a prespecified effect
d with prespecified power of (1 b)  100% at a signifi-
cance level a). Note that most programs and formulas
give the number of subjects per arm, so for the total
sample size, this needs to be doubled. After that, we
multiply this total sample size by the variance infla-
tion factors to account for the multilevel stepped-
wedge design. For a ‘‘standard’’ stepped-wedge
design, the total sample size at each measurement
time Ntot, t (i.e. the total required number of level-1
units across all clusters and arms at each measure-
ment time/period) is
Ntot, t =VIF  Ntot,PG1=VIFrm  VIFp  Ntot,PG1 ð9Þ
and dividing this by the number of level-1 units per
cluster at each measurement yields the total required
number of clusters (I). Dividing this total number of
clusters by the number of steps gives the number of
clusters per sequence c= I=s (in the hybrid design after
accounting for the fraction b). The parameters r and
VIFp needed to calculate VIF follow from Table 2 for
three-level and four-level designs or from the arguments
used in the SF for p-levels designs.
Instead of calculating the total sample size (or num-
ber of clusters needed), power for a range of feasible
configurations (i.e. number of clusters, sample size at
different levels, and intracluster correlations) could be
Table 1. Notations in this article illustrated in the CHANGE trial setting.
Parameter Meaning (in the four-level CHANGE trial)
Yit The average of outcome Y in cluster i at time t, that is, the dot means averaging over all sub-units
d Treatment effect
bt Time effect at measurement time/period t
Xit Design matrix: Xit = 1 if cluster i has intervention at time t, and Xit = 0 if it is in control condition
s2tot Total variance of level 1 units unconditional, that is, regardless of the cluster they belong to
r12 True (population) value of correlation of level-1 units (observations) within a level-2 unit (nurse)
r23 True (population) value of correlation of level-2 units (nurse) within a level-3 unit (ward)
~r23 Sample estimated value of correlation of level-2 units (nurse) within a level-3 unit (ward)
r34 True (population) value of correlation of level-3 units (ward) within a level-4 unit (nursing home)
~r34 Sample estimated value of correlation of level-3 units (ward) within a level-4 unit (nursing home)
n1 Number of level-1 units (observations) per level-2 unit (nurse)
n2 Number of level-2 units (nurses) per level-3 unit (ward)
n3 Number of level-3 units (wards) per level-4 unit (nursing home)
s Number of sequences in a stepped wedge (also if part of a larger design)
c Number clusters in a sequence of a stepped-wedge design
T Number of measurement times/periods (including the baseline)
I Total number of clusters (nursing homes)
t2 Cov(Yit, Yis): covariance between averages of the same cluster at different times t and s
t2+s2 Var(Yit): variance of a cluster average at a time t
s21 Variance at level 1, that is, variance of level-1 units (observations) within their level-2 unit (nurse)
s22 Variance at level 2, that is, variance of level-2 units (nurses) within their level-3 unit (ward)
s23 Variance at level 3, that is, variance of level-3 units (wards) within their level-4 unit (nursing home)
s24 Variance at level 4, that is, variance between level-4 units (nursing homes)
VIFp Variance inflation factor due to the multilevel structure of the data having p levels
r Corr(Yit, Yis) correlation between averages of the same cluster at different times t and s
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calculated to see which configuration, if any, provides
sufficient power. This can be done using the usual
power formula
Power dð Þ=F dffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
var d^
 r  z1a=2
0
BB@
1
CCA
where F is the cumulative distribution function of the
standard normal distribution and z1a=2 is its
100%  (1 a=2) percentile.
To calculate var(d^), equation (5a) with s2 and t2 can
be applied or equation (5b) with r and var(Yit) using the
appropriate formulas for s2, t2, r, var(Yit) in Table 2.
The latter comes down to using the variance inflation
factors, that is, var(d^)=VIFrm  VIFp  4s2tot=Ntot, t where
Ntot, t is the total number of level-1 units in the trial at
each measurement time/period. For the standard stepped
wedge, we can rewrite this to
var(d^)= 4s2tot
3
2
 1 rð Þ  1+ sr½ 
s 1
s
   1+ s
2
r
   1
I
 1+ n1  1ð Þ12
 
n1
 1+ n2  1ð Þ~r23½ 
n2
  
1+ np1  1
 
~rp1, p
h i
np1
ð10Þ
in order to investigate the impact of various design
parameters on the power. Figure 3 shows
VIFSW :cPG1(s, r) for increasing values of r for various
values of s, the number of sequences.
For a small number of clusters, the sample size and
power formulas hold only approximately. For continu-
ous, normally distributed outcomes, this is because of
the low degrees of freedom, while for binary/rate out-
comes, this is because formulas (2) and (4) depend on
approximating the statistical distribution of cluster
averages by a normal distribution using the central
limit theorem. Therefore, we recommend the use of
simulation studies to check power and also type I error
for designs with a small number of clusters. However,
the formulas in this article can be used to see whether
feasible designs (i.e. in terms of number of clusters and/
or number of measurements) would be worth such fur-
ther investigation.
Binary and incidence outcomes
As the argumentation underlying the formulas relies on
approximating the statistical distribution of cluster
averages by the normal distribution using the central
limit theorem, the formulas can be used for binary and
incidence outcomes as well, provided the number of
clusters is sufficiently large. We now discuss what value
for s2tot could be taken for non-small and small samples.
If we take a two-level design and a binary outcome
as an example, we can model the trial hierarchically as
follows. Each subject j in cluster i has a binary outcome
Bij that is 1 with probability pi, when cluster i is in the
control condition, and with probability pi+ d, when
cluster i is in the invention condition. The probabilities
pi vary over the clusters according to some distribution
with mean m and variance s2c . Then, the within-cluster
variance in cluster i is pi(1 pi) in the control condi-
tion. Over all clusters in the control condition, the
expected total variance, that is, the variance of a level 1
unit regardless (unconditional) of the cluster it
comes from, is s2tot=m(1 m), which can be decom-
posed into an expected within-cluster variance of
s21=E½pi(1 pi)=m(1 m) s2c and between-cluster
variance of s22= var(pi)= s
2
c = r12  s21=(1 r12)
(SF9). Because these expectations are averages that
hold when the number of clusters is sufficiently large, it
may make sense to take the following small-sample
strategy. If we think that cluster-specific probabilities pi
will in practice mostly be between pmin and pmax, we
take within that range the value pclose that is closest to
0:5, and set s21= pclose(1 pclose), because that is the
maximum value of the within-cluster variances
pi(1 pi) in the clusters in control condition. Noting
that s21=(1 r12)  s2tot, we set the total variance to
s2tot, control= pclose(1 pclose)=(1 r12). The same reason-
ing could be applied when clusters are in the interven-
tion condition, and thus, the largest (or average) of the
two could be taken as s2tot. This result also holds when
there are more than two levels.
For a rate (incidence) outcome, the count (or rate)
outcome of subject j in cluster i is Rij that has expected
value (average) li, and these li have mean l and var-
iance s2c . For a cluster in the control condition, the
expected total variance, that is, the variance of a level-1
Figure 3. Variance inflation factor for the standard stepped
wedge as a function of the correlation r between cluster
averages over time. From top to bottom, the curves for the
number of sequences s= 2, 3, 4, 5, 6, 10, 20 are shown.
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unit unconditional of the cluster it comes from, is
s2tot= l+ s
2
c = l=(1 r12) with s21=E li½ = l the
expected (i.e. average over the clusters) within-cluster
variance and s22= var(Ri)= s
2
c = r12  s21=(1 r12) the
between-cluster variance. A conservative small sample
strategy could then be to take s21= lmax, and thus set
s2tot, control= lmax=(1 r12), if we think that cluster-
specific rate li will in practice mostly fall between lmin
and lmax. A similar reasoning applies when a cluster is
in the intervention condition and the average or maxi-
mum of these two could be taken as s2tot.
To illustrate sample size versus power calcula-
tions, for different endpoints, and small versus large
sample considerations, we present two examples in
the setting of the CHANGE trial. These were not the
final calculations for this trial but similar to those
performed.
Example 1: binary outcome in four-level standard
stepped wedge
As a first example, we calculate power for hand hygiene
compliance (a binary outcome) in a four-level standard
stepped wedge using the following assumptions. The
duration of the trial only allows four sequences (s= 4).
The target effect size is an improvement from 20% to
35% (d= 0:15). It is assumed that the correlation
among measurements within a nurse would be rather
high (r12= 0:6), while the correlation among nurses
within a ward would be smaller (r23= 0:05) and that of
wards within a nursing home even smaller (r34= 0:01).
Based on feasibility, around five observations (n1= 5)
per nurse, 15 nurses (n2= 15) per ward, maximally five
wards per nursing home (n3= 5), and four nursing
homes (I= n4= 4) would be possible. Given the small
number of clusters (four nursing homes), it could make
sense to take a conservative approach for the total var-
iance s2tot as was discussed above. If the level-1 prob-
abilities are closest to 0.5 at pclosest= 0:40 (instead of
0.35) in the control condition and at pclosest= 0:25
(instead of 0.20) in the experimental condition, respec-
tively, we take the average of the corresponding var-
iances s21=(0:40  0:60+ 0:25  0:75)=2= 0:21375 and
given that (1 r12)s2tot=s21, the total variance is then
s2tot= 0:21375=(1 0:6)= 0:534375. If different nurses
are sampled in each measurement time/period, level-2
and -1 units (nurses and measurements) are not
repeated, and using the formulas in Table 2 (second sce-
nario of the four-level standard stepped wedge)
t2=s24+
s23
n3
= r34r23r12+
(1 r34)r23r12
n3
	 

s2tot
= 0:0003+
0:0297
5
	 

 0:534375 ffi 33:345  104
and
s2=
s22
n3n2
+
s21
n3n2n1
=
1 r23ð Þr12
n3n2
+
1 r12
n3n2n1
	 

 s2tot=
0:57
5  15+
0:4
5  15  5
	 

 0:534375 ffi 46:313104
so that
var(d^)=
6
I  s 1
s
   s2  1+ s2  t2
s2+ 1+ s
2
 
t2
" #
ffi 6
4  4 1
4
   46:313  104
 1+
4
2
 33:345  104
46:313  104+ 1+ 4
2
   33:345  104
" #
ffi 26:967  104
and Power (d)=F(d=
ffiffiffi^
d
p
 z1a=2)=F(0:15=
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
26:967  104
p

1:96)=F(0:928515)= 0:8234. Figure 4 gives an
impression of the sensitivity when one of the sample
sizes or intracluster correlations is varied while the oth-
ers are kept constant.
Example 2: rate outcome in a three-level standard
stepped wedge
As second example, we use the variance inflation factor
to calculate sample size for infection incidence (a rate).
These rates are measured on patients within wards in
nursing homes; hence, a 3-level design. We would
expect the correlation of infection rates within wards to
be high (r12= 0:7), while infections in one ward would
not automatically increase infections in another ward
within the same nursing home, so a low correlation of
ward-infection rates within a nursing home
(r23= 0:01). The effect of interest is a decrease from 11
to 5 infections per 1000 resident days (d= 6  103).
Anticipating a large number of clusters, we do not take
s21= lmax the maximum of the cluster-specific rates per
condition but the average of the cluster-specific rate l
for each condition. Thus, s21=(lctl + lexp)=2= 8 103
and s2tot=s
2
1= 1 r12ð Þ ffi 26:67  103. The total sam-
ple size in an equal size parallel group individually ran-
domized design needed to detect this difference with 0.8
power at a significance level of 0.05 is
Ntot,PG1= 2  2  z10:05
2
+ z0:8
 2
 s2tot=d2 ffi 2
2  7:85  26:67  103= 6  103 2= 23, 262
With n1= 10 patients per ward and n2= 4 wards
per nursing home, the variance inflation due to cluster-
ing is VIF3= ½1+(n1  1)12 1+(n2  1)  fr23  n1½
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r12=(1+(n11)r12)g=½7:3½1+3f0:0110 0:7=(7:3)g
= 7:51. If we assume that only patients are cross-
sectionally measured, we are in the second three-level
scenario (Table 2) and r= r12  n1  ½1+(n2  1)
r23=VIF3= 0:7  10  ½1:03=½7:51 ffi 0:96. Thus, the
variance inflation due to the stepped-wedge design is
VIFSW :cPG1=
3
2
 1 rð Þ  1+ sr½ 
s 1
s
   1+ s
2
r
 
=
3
2
 1 0:96ð Þ  1+ 4  0:96½ 
4 1
4
   1+ 4
2
 0:96  ffi 0:026
and the total variance inflation is
VIFSW = 0:026  7:51 ffi 0:20. Then, the total sample
size needed per measurement time/period is
Ntot,PG1  VIFSW = 23, 262  0:20 ffi 4652 and the number
of nursing homes (clusters) needed Ntot,PG1
VIFSW=n1n2 ffi 4652=(10  4) ffi 116, so four groups of
29 clusters should suffice.
Programs (SAS and MS Excel) to facilitate calcu-
lations are provided via https://github.com/steventeer-
enstra/multilevel-stepped-wedge and in the SF (SAS
program only).
Discussion
Power and sample size formulas for stepped-wedge
designs are typically restricted to two or three levels.7,9
In this article, these formulas were extended to designs
with more levels and it was demonstrated that they can
either be expressed in terms of variance components or
intracluster correlations. The latter expression clearly
shows the separate effect of the multilevel structure
within time and the stepped-wedge structure over time,
similar to what has been shown for other designs but
with two levels.10,11
From the formulas, it can be seen that the different
design parameters have the following impact on power
and sample size:
(I): Increasing the number of clusters I increases power
(SF7.1).
(s): Increasing the number of sequences s increases
power,1,4,9 except for the case of the hybrid design and
when the total cluster size over all measurements is con-
stant (SF7.1).
(ni): Increasing the sample size at any level increases
power (SF7.2, Figure 4). We can achieve any desired
power by sufficiently increasing the sample size at any
of the levels that are measured as cohort and also by
increasing the sample size of the first ‘‘cross-sectional’’
level that is below those levels (SF7.3). In particular,
this also applies to the two-level stepped-wedge design,
so by increasing the number of cross-sectionally mea-
sured subjects, we can reach any power level. This is in
contrast with the parallel arm cluster-randomized trial
that can plateau (potentially below 80%) if the number
of subjects is increased indefinitely.12 As a consequence,
a lack of power due to a limited number of clusters can
be compensated by increasing the sample size at partic-
ular lower levels. As one can see in Figure 4, not only
the sample size at level 3, but also at level 2 can increase
the power to 1, but power plateaus below 0.9 when
increasing the sample size at level 1. This behavior can
most easily be understood in a two-level stepped-wedge
trial. As the random effect of a cluster is assumed not
to vary over time, the within-cluster comparison is actu-
ally a comparison of all subjects before switching to the
intervention and after, because the random effect of
cluster drops out of the equation. This means that the
within-cluster comparisons can become arbitrarily pre-
cise with increasing level 1 sample size and this drives
the power to 1.
(ru, u+ 1): Unlike in parallel group cluster-randomized
trials, an increase in the intracluster correlation coeffi-
cients does not necessarily mean a decrease in power,
but actually may increase power in some situations as
can be observed in Figure 4. This is because increasing
an intracluster correlation ru, u+ 1 influences the power
both via the variance inflation factor due to the multile-
vel structure, VIFp, and via the stepped-wedge design
variance inflation factor, VIFSW :cPG1. The first factor,
VIFp, will linearly increase with ru, u+ 1 (Formula (6)).
However, VIFSW :cPG1 will generally first increase and
then decrease when an intracluster correlations ru, u+ 1
increases. This is because with increasing ru, u+ 1, the
correlation r between averages of the same cluster at
different times/periods will increase as well (SF7.4), but
VIFSW (s)(r) will first increase with increasing r until
some turning point and then decrease as is illustrated
in Figure 3. Intuitively, this decrease can be understood
because the standard stepped wedge depends on
between- and within-cluster comparisons. The between-
cluster comparisons will become less precise when the
correlation ru, u+ 1 increases, but the precision will be
dominated by the within-cluster comparisons for larger
ru, u+ 1. In the within-cluster comparisons, the random
effects for clustering drop out, and so increasing ru, u+ 1
will mean that the units at level u before and after the
switch will be better correlated, so the within-cluster
comparison will be more precise. All in all, an increas-
ing intracluster correlation ru, u+ 1 can thus give differ-
ent patterns for the variance inflation and power. For
example, when the increasing behavior of VIFp domi-
nates for small ru, u+ 1, while for larger ru, u+ 1 the
decreasing behavior of VIFSW (s) dominates, then we
would see power first decrease and then increase as a
function of ru, u+ 1. Another typical behavior is that
power decreases with increasing ru, u+ 1, because the
increasing behavior of VIFp dominates that of VIFSW (s)
for all values of ru, u+ 1. Both behaviors can be seen in
Figure 4.
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Both increasing sample size and intracluster correla-
tions coefficients can have unexpected power properties
due to the random effects canceling out. Therefore, one
may question how realistic it is to assume that the ran-
dom effects (of a cluster) are not varying over time. This
assumption implies that the correlation of two subjects
within a cluster is the same whether they are measured
at the same time t or at different times. It also implies
that the correlation r of cluster means at different times
only depends on intracluster correlations ru, u+ 1, that
is, correlations at a fixed time (Table 2). For some out-
comes in type-2 diabetes, Martin et al.13 found this not
to be the case in a two-level setting. More empirical
research is needed to see whether and when an assump-
tion of constant correlation over time is reasonable; if
this is not the case, then power will be lower than what
is calculated from our formulas.11,14
The variance components or intracluster correlation
coefficients needed for the calculations should prefer-
ably be estimated from studies with similar outcomes
and context. These studies should have the same num-
ber of levels, but do not need to be stepped wedge,
prospective, or randomized. In the absence of such
studies, content-matter specialists could provide plausi-
ble values, and they could do so either in terms of var-
iance components or intracluster correlations. Given
the uncertainties in these educated guesses, we recom-
mend that a range of plausible values for each of these
parameters be considered.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with
respect to the research, authorship, and/or publication of this
article.
Funding
This work was supported in part by the Netherlands
Organisation for Health Research and Development
(ZonMw; grant no. R522002009).
Supplemental material
Supplemental material for this article is available online.
Figure 4. Impact of cluster size and intracluster correlations at different levels in a ‘‘standard’’ stepped wedge. Power of the 4 level
‘‘standard’’ stepped-wedge trial of Example 1 when varying either one sample size (part a-c) or one intracluster correlation (part d-f)
at the specified level while keeping the other sample sizes and intracluster correlations constant. The vertical reference lines indicate
the values of sample size and intracluster correlation as in Example 1 (r12= 0:6, r23= 0:05, r34= 0:01, n1= 5, n2= 15,
n3= 5, n4= I= 4).
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